ID: ALA2396940

Max Phase: Preclinical

Molecular Formula: C5H9N5O

Molecular Weight: 155.16

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CC(=O)N=C(N)N=C1N

Standard InChI:  InChI=1S/C5H9N5O/c1-10-2-3(11)8-4(6)9-5(10)7/h2H2,1H3,(H4,6,7,8,9,11)

Standard InChI Key:  GWLHJCBDRHPHIO-UHFFFAOYSA-N

Associated Targets(Human)

Growth factor receptor-bound protein 2 663 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 155.16Molecular Weight (Monoisotopic): 155.0807AlogP: -1.91#Rotatable Bonds: 0
Polar Surface Area: 97.07Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.85CX Basic pKa: 8.91CX LogP: -2.12CX LogD: -3.53
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.43Np Likeness Score: 0.58

References

1. Simister PC, Luccarelli J, Thompson S, Appella DH, Feller SM, Hamilton AD..  (2013)  Novel inhibitors of a Grb2 SH3C domain interaction identified by a virtual screen.,  21  (14): [PMID:23182216] [10.1016/j.bmc.2012.10.023]

Source